OCTRI announces 2015 Catalyst Award recipients

The Oregon Clinical & Translational Research Institute (OCTRI) has funded four projects designed to enhance translational research at OHSU. These novel, collaborative, multidisciplinary studies will lead to further research and funding in translational research. The funding was made available through institutional support of OCTRI from the School of Medicine (Research Roadmap initiative) and the Office of the Senior Vice President for Research.

Congratulations to the 2015 Catalyst Award winners:

Joshi Alumkal, M.D.

“Bromodomain Inhibition For The Treatment Of Lethal Prostate Cancer”



Willi Horner-Johnson, Ph.D.

“Reproductive Health of Women with Disabilities Initiative”



Stephen Lloyd


Stephen Lloyd, Ph.D.

“DNA Glycosylases: Novel Targets for Small Molecule-induced Synthetic Lethality”


William Messer


William Messer, M.D., Ph.D.

“Long-term DENV immunity in a human cohort”


OCTRI Catalyst funding is specifically intended to enable the development of compelling new grant applications that will sustain the proposed research activity. Please see the OCTRI Funding Opportunities page for more information or contact Colleen Lay.

See full project abstracts here.
For more information on OCTRI’s resources and services, please visit: www.octri.org.

Bookmark and Share

Comments are closed.

About the Author

Erica is the Communications Coordinator for Oregon Clinical & Translational Research Institute.

Welcome to the Research News Blog

Welcome to the Research News Blog

OHSU Research News is your portal to information about all things research at OHSU. Find updates on events, discoveries, and important funding information.

Participation Guidelines

Remember: information you share here is public; it isn't medical advice. Need advice or treatment? Contact your healthcare provider directly. Read our Terms of Use and this disclaimer for details.